Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: Complement activation and therapeutic approaches

Neurobiology of Aging

Volumn 17, Issue 5, 1996, Pages 781-787

  Chen, Suio ^a   Frederickson, Robert C A ^a   Brunden, Kurt R ^a  

^a GUILFORD PHARMACEUTICALS INC   (United States)

Author keywords

Alzheimer's disease; Astrocytes; A peptide; complement; Inflammation; Microglia

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; COMPLEMENT ACTIVATION; HUMAN; HUMAN CELL; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; PRIORITY JOURNAL;

EID: 0030250758     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-4580(96)00103-0     Document Type: Article

References (58)

1. 1. Araujo, D. M.; Cotman, C. W. β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaqes in Alzheimer's disease. Brain Res. 569:141-145; 1992.
2. 2. Bethea, J. R.; Gillespie, G. Y.; Chung, I. Y.; Benveniste, E. N. Tumor necrosis factor production and receptor expression by a human astroglioma cell line. J. Neuroimmunol. 30:1-13; 1990.
3. 3. Cacabelos, R.; Alvarez, X. A.; Fernandez-Novoa, L.; Franco, A.; Mangues, R.; Pellicer, A.; Nishimura, T. Brain interleukin-1β in Alzheimer's disease and vascular dementia. Methods Find. Exp. Clin. Pharmacol. 16:141-151; 1994.
4. 4. Cai, X.-D.; Golde, T. E.; Younkin, S. G. Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259:514-516; 1993.
5. 5. Canning, D. R.; McKeon, R. J.; DeWitt, D. A.; Perry, G.; Wujek, J. R.; Frederickson, R. C. A.; Silver, J. β-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth. Exp. Neurol. 124:289-298; 1993.
6. 6. Citron, M.; Oltersdorf, T.; Haass, C.; McConlogue, L.; Hung, A. Y.; Seubert, P.; Vigo-Pelfrey, C.; Lieberburg, I.; Selkoe, D. J. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360:672-674; 1992.
7. 7. Cotman, C. W.; Pike, C. J.; Copani, A. β-Amyloid neurotoxicity: A discussion of in vitro findings. Neurobiol. Aging 13:587-590; 1992.
8. 8. Donnelly, R. J.; Friedhoff, A. J.; Beer, B.; Blume, A. J.; Vitek, M. P. Interleukin-1 stimulates the beta-amyloid precursor protein promoter. Cell. Mol. Neurobiol. 10:485-495; 1990.
9. 9. Eikelenboom, P.; Stam, F. C. Immunoglobulins and complement factors in senile plaques. Acta Neuropathol. 57:239; 1982.
10. 10. Fillit, H.; Ding, W.; Buee, L.; Kalman, J.; Alstiel, L.; Lawlor, B.; Wolf-Klein, G. Elevated circulating tumor necrosis factor in Alzheimer's disease. Neurosci. Lett. 129:318-320; 1991.
11. 11. Fontana, A.; Hengartner, H.; de Tribolet, N.; Weber, E. Glioblastoma cells release interleukin-1 and factors inhibiting interleukin-2-mediated effects. J. Immunol. 132:1837-1844; 1984.
12. 12. Forloni, G.; Demicheli, F.; Giorgi, S.; Bendotti, C.; Angeretti, N. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: Modulation by interleukin-1. Mol. Brain Res. 16:128-134; 1992.
13. 13. Frederickson, R. C. A. Astroglia in Alzheimer's disease. Neurobiol. Aging 13:239-253; 1992.
14. 14. Frederickson, R. C. A.; Brunden, K. R. New opportunities in AD research: Roles of immunoinflammatory responses and glia. Alzheimer Dis. Assoc. Disord. 8:159-165; 1994.
15. 15. Gasque, P.; Ischenko, A.; Legoedec, J.; Mauger, C.; Schouft, M.-T.; Fontaine, M. Expression of the complement classical pathway by human glioma in culture: A model for complement expression by nerve cells. J. Biol. Chem. 268:25068-25074; 1993.
16. 16. Giulian, D.; Baker, T. J.; Shih, L.; Lachman, L. B. Interleukin-1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 164:594-604; 1986.
17. 17. Goate, A.; Chartier-Harlin, M.-C.; Mullan, M.; Brown, J.; Crawford, F.; Fidani, L.; Giuffra, L.; Haynes, A.; Irving, N.; James, L.; Mant, R.; Newton, P.; Rooke, K.; Roques, P.; Talbot, C.; Pericak-Vance, M.; Roses, A.; Williamson, R.; Rossor, M.; Owen, M.; Hardy, J. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706; 1991.
18. 18. Goldgaber, D.; Harris, H. W.; Hla, T.; Maciag, T.; Donnelly, R. J.; Jacobsen, J. S.; Vitek, M. P.; Gajdusek, D. C. Interleukin 1 regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. USA 86:7606-7610; 1989.
19. 19. Griffin, S. T.; Stanley, L. C.; Ling, C.; White, L.; MacLeod, V.; Perrot, L. J.; White, C. L.; Araoz, C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86:7611-7615; 1989.
20. 20. Haga, S.; Ikeda, K.; Sato, M.; Ishii, T. Synthetic Alzheimer amyloid β/A4 peptides enhance production of complement C3 component by cultured microglial cells. Brain Res. 601:88-94; 1993.
21. 21. Hagmann, W. K.; Sindelar, R. D. Potential therapeutic modifiers of the complement cascade. Ann. Rep. Med. Chem. 27:199-208; 1992.
22. 22. Hoke, A.; Canning, D. R.; Malemud, C. J.; Silver, J. Regional differences in reactive gliosis induced by substrate-bound β-amyloid. Exp. Neurol. 130:56-66; 1994.
23. 23. Ishii, T.; Haga, S.; Kametani, F. Presence of immunoglobulins and complements in the amyloid plaques in the brain of patients with Alzheimer's disease. In: Pouplard-Barthelaix, A.; Emile, J.; Christen, Y., eds. Immunology and Alzheimer's disease. Berlin: Springer Verlag; 1988:17-29.
24. 24. Itagaki, S.; McGeer, P. L.; Akiyama, H.; Zhu, S.; Selkoe, D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol. 24:173-182; 1989.
25. 25. Itagaki, S.; Akiyama, H.; Saito, H.; McGeer, P. L. Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease. Brain Res. 645:78-84; 1994.
26. 26. Jiang, H.; Burdick, D.; Glabe, C. G.; Cotman, C. W.; Tenner, A. J. β-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J. Immunol. 152:5050-5059; 1994.
27. 27. Jiang, H.; Cooper, B.; Robey, F. A.; Gewurz, H. DNA binds and activates complement via residues 14-26 of the human C1q A chain. J. Biol. Chem. 267:25587-25601; 1992.
28. 28. Jiang, H.; Robey, F. A.; Gewurz, H. Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human C1q A chain. J. Exp. Med. 175:1373-1379; 1992.
29. 29. Johnson, S. A.; Lampert-Etchells, M.; Pasinetti, G. M.; Rozovsky, I.; Finch, C. E. Complement mRNA in the mammalian brain: Responses to Alzheimer's disease and experimental brain lesioning. Neurobiol. Aging 13:641-648; 1992.
30. 30. Koo, E. H.; Park, L.; Selkoe, D. J. Amyloid β-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth. Proc. Natl. Acad. Sci. USA 90:4748-4752; 1993.
31. 31. Lee, S. C.; Liu, W.; Dickson, D. W.; Brosnan, C. F.; Berman, J. W. Cytokine production by human fetal microglia: Differential induction by lipopolysaccharide and IL-1β. J. Immunol. 150:2659-2667; 1993.
32. 32. LeVine, H. Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution. Protein Sci. 2:404-410; 1993.
33. 33. Lorton, D.; Kocsis, J. M.; King, L.; Madden, K.; Brunden, K. R. β-Amyloid(25-25) enhances release of interleukin-1β from activated human monocytes. Soc. Neurosci. Abstr. 19:186; 1993.
34. 34. Lue, L.-F.; Rogers, J. Full complement activation fails in diffuse plaques of the Alzheimer's disease cerebellum. Dementia 3:308-313; 1992.
35. 35. Mandybur, T. I.; Chuirazzi, B. A. Astrocytes and the plaques of Alzheimer's disease. Neurology 40:635-639; 1990.
36. 36. McGeer, P. L.; Kawamata, T.; Walker, D. G. Distribution of clusterin in Alzheimer brain tissue. Brain Res. 579:337-341; 1992.
37. 37. McGeer, P. L.; Akiyama, H.; Itagaki, S.; McGeer, E. G. Immune system response in Alzheimer's disease. Can. J. Neurol. Sci. 16:516-527; 1989.
38. 38. Murrell, J.; Farlow, M.; Ghetti, B.; Benson, M. D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254:97-99; 1991.
39. 39. Painter, R. H. The C1q receptor site on human immunoglobulin G. Can. J. Biochem. Cell Biol. 62:418-425; 1984.
40. 40. Perlmutter, L. S.; Scott, S. A.; Barron, E.; Chui, H. C. MHC class II-positive microglia in human brain: Association with Alzheimer lesions. J. Neurosci. Res. 33:549-558; 1992.
41. 41. Pike, C. J.; Burdick, D.; Walencewicz, A. J.; Glabe, C. G.; Cotman, C. W. Neurodegeneration induced by β-amyloid peptides in vitro; The role of peptide assembly state. J. Neurosci. 13:1676-1687; 1993.
42. 42. Pike, C. J.; Cummings, B. J.; Monzavi, R.; Cotman, C. W. β-Amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience 63:517-531; 1994.
43. 43. Pike, C. J.; Walencewicz, A. J.; Glabe, C. G.; Cotman, C. W. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563:311-314; 1991.
44. 44. Rogers, J.; Cooper, N. R.; Webster, S.; Schultz, J.; McGeer, P. L.; Styren, S. D.; Civin, W. H.; Brachova, L.; Bradt, B.; Ward, P.; Lieberburg, I. Complement activation by β-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA 89:10016-10020; 1992.
45. 45. Rose, N. R.; Freedman, H.; Fahey, J. L. Manual of clinical laboratory immunology, 3rd ed. Washington, DC: American Society for Microbiology; 1986:58.
46. 46. Rozemuller, J. M.; Eikelenboom, P.; Pals, S. T.; Stam, F. C. Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family. Neurosci. Lett. 101: 288-292; 1989.
47. 47. Simmons, L. K.; May, P. C.; Tomaselli, K. J.; Rydel, R. E.; Fuson, K. S.; Brigham, E. F.; Wright, S.; Lieberburg, I.; Becker, G. W.; Brems, D. N.; Li, W. Y. Secondary structure of amyloid peptide correlates with neurotoxicity in vitro. Mol. Pharmacol. 45:373-379; 1994.
48. 48. Snyder, S. W.; Wang, G. T.; Barrett, L.; Ladror, U. S.; Casuto, D.; Lee, C. M.; Krafft, G. A.; Holzman, R. B.; Holzman, T. F. Complement C1q does not bind monomeric β-amyloid. Exp. Neurol. 128:136-142; 1994.
49. 49. Suzuki, N.; Iwatsubo, T.; Odaka, A.; Ishibashi, Y.; Kitada, C.; Ihara, Y. High tissue content of soluble β1-40 is linked to cerebral amyloid angiopathy. Am. J. Pathol. 145:452-460; 1994.
50. 50. Thomas, W. E. Brain macrophages: Evaluation of microglia and their function. Brain Res. Rev. 17:61-74; 1992.
51. 51. Tooyama, I.; Kimura, H.; Akiyama, H.; McGeer, P. L. Reactive microglia express class I and class II major histocompatibility antigens in Alzheimer's disease. Brain Res. 523:273-280; 1990.
52. 52. Walker, D. G.; Kim, S. U.; McGeer, P. L. Complement and cytokine gene expression in cultured microglia derived from postmortem human brains. J. Neurosci. Res. 40:478-493; 1995.
53. 53. Wisniewski, H. M.; Wegiel, J.; Strojny, P.; Wang, K.-C.; Kim, K.-S.; Burrage, T. Ultrastructural morphology and immunocytochemistry of β-amyloid classical, primitive and diffuse plaques. In: Ishii, T.; Allsop, D.; Selkoe, D. J., eds. Frontiers of Alzheimer research. New York: Elsevier; 1991:99-108.
54. 54. Wisniewski, H. M.; Bancher, C.; Barcikowska, M.; Wen, G. Y.; Gurie, J. Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease. Acta Neuropathol. 78:337-347; 1989.
55. 55. Wood, J. A.; Wood, P. L.; Ryan, R.; Graff-Radford, N. R.; Pilapil, C.; Robitaille, Y.; Quirion, R. Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein. Brain Res. 629:245-252; 1993.
56. 56. Wujek, J. R.; Dority, M. D.; Frederickson, R. C. A.; Brunden, K. R. Deposits of A fibrils are not toxic to cortical and hippocampal neurons in vitro. Neurobiol. Aging 17:107-113; 1996.
57. 57. Ying, S.-C.; Gewurz, A. T.; Jiang, H.; Gewurz, H. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q. J. Immunol. 150:169-176; 1993.
58. 58. Zhan, S.-S.; Veerhuis, R.; Janssen, I.; Kamphorst, W.; Eikelenboom, P. Immunohistochemical distribution of the inhibitors of the terminal complement cascade in Alzheimer's disease. Neurodegen. 3:111-117; 1994.